title: Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes.
abstract: Granulocyte-colony stimulating factor (G-CSF) binds to a specific cell surface receptor and induces signals for growth and differentiation in cells of granulocyte hematopoietic lineage. In order to understand how G-CSF binding initiates signals into these cells, we have studied its interactions with the entire extracellular domain of the receptor (sG-CSFR). The sG-CSFR was purified from CHO cell conditioned media with a G-CSF affinity column, resting in a preparation fully competent for ligand binding. However, when sG-CSFR was purified by conventional means, i.e., without affinity chromatography, only about half was competent. Therefore, all studies were carried out using affinity-purified material. The sG-CSFR exhibited a weak self-association into a dimer with a dissociation constant of 200microM in the absence of G-CSF. Addition of G-CSF dimerizes the receptor, with a preferred stoichiometry of 2 G-CSF molecules plus 2 receptors. Unexpectedly, receptor-receptor interactions rather than through two receptors binding to the same G-CSF molecule; i.e., G-CSF is a monovalent ligand. G-CSF binding to the receptor monomer occurs with high affinity. The binding of G-CSF also enhances the receptor-receptor dimerization; when G-CSF is bound to both receptors, dimerization is enhanced 2000-fold, while the interaction of a 1:1 receptor-ligand complex with a second ligand-free receptor is enhanced 80-fold. Thus, the mechanism of receptor dimerization is fundamentally different than that of related cytokine receptors such as growth hormone and erythropoietin receptors. Circular dichroic spectra showed a small but significant conformational change of receptor upon binding G-CSF. This is consistent with the idea that G-CSF binding alters the conformation of the receptor, resulting in an increase in receptor-receptor interactions.
authors.affiliation: Amgen Inc., Amgen Center, Thousands Oaks, California 91320-1789, USA.
authors.forename: T
authors.initials: T
authors.lastname: Horan
authors.forename: J
authors.initials: J
authors.lastname: Wen
authors.forename: L
authors.initials: L
authors.lastname: Narhi
authors.forename: V
authors.initials: V
authors.lastname: Parker
authors.forename: A
authors.initials: A
authors.lastname: Garcia
authors.forename: T
authors.initials: T
authors.lastname: Arakawa
authors.forename: J
authors.initials: J
authors.lastname: Philo
mesh_terms: D000818:Animals; D016466:CHO Cells; D002846:Chromatography, Affinity; D002942:Circular Dichroism; D006224:Cricetinae; D016179:Granulocyte Colony-Stimulating Factor / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008027:Light; D011487:Protein Conformation; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000302:isolation & purification / Q000378:metabolism*; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000378:metabolism; D012542:Scattering, Radiation; D012995:Solubility
chemical_list: D008024:Ligands; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor